Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Peck-Radosavljevic, M; Sieghart, W; Kölblinger, C; Reiter, M; Schindl, M; Ulbrich, G; Steininger, R; Müller, C; Stauber, R; Schöniger-Hekele, M; Gschwendtner, M; Plank, C; Funovics, M; Graziadei, I; Lammer, J; Gruenberger, T; Gastl, G; Karnel, F; Austrian Association of Gastroenterology,Hepatology (GGH); Austrian Society of Interventional Radiology (GIR); Austrian Society of Hematology and Oncology (GHO); Austrian Society for Surgical Oncology (ASSO).
Austrian Joint GGH-GIR-GHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.
Wien Klin Wochenschr. 2012; 124(3-4):104-110
Doi: 10.1007/s00508-011-0056-2
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Stauber Rudolf
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) is one of the most frequently applied standard treatments for this disease. The role for TACE is fairly well defined within the most widely used treatment algorithm for HCC, die Barcelona Clinic Liver Cancer (BCLC) staging system and treatment algorithm. But no general treatment algorithm will go into the technical details of any procedure and several patients will not fit ideally into the patient groups predefined in BCLC or any other treatment algorithm. Furthermore, indications and contraindications sometimes are viewed differently by the various medical specialties involved in taking care of such patients. We present here the joint expert position statement of the Austrian Societies of Gastroenterology and Hepatology (ÖGGH), Interventional Radiology (ÖGIR), Hematology and Oncology (ÖGHO), and Surgical Oncology (ASSO) on the technical aspects, indications, and contraindication for the use of TACE in the management of HCC.
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Agents - therapeutic use
- Antineoplastic Agents -
- Carcinoma, Hepatocellular - therapy
- Chemoembolization, Therapeutic - standards
- Humans -
- Liver Neoplasms - therapy
- Medical Oncology - standards
- Practice Guidelines as Topic -
- Find related publications in this database (Keywords)
- Hepatocellular carcinoma
- TACE
- transarterial chemoembolization
- BCLC
- drug-eluting beads